0001971857-23-000220.txt : 20230607 0001971857-23-000220.hdr.sgml : 20230607 20230607141741 ACCESSION NUMBER: 0001971857-23-000220 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230607 DATE AS OF CHANGE: 20230607 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Arcus Biosciences, Inc. CENTRAL INDEX KEY: 0001724521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473898435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38419 FILM NUMBER: 23998583 BUSINESS ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 694-6200 MAIL ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Goeltz II Robert C. CENTRAL INDEX KEY: 0001653881 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001653881 XXXXXXXX LIVE 0001724521 Arcus Biosciences, Inc. 001-38419 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200 Goeltz II Robert C. Officer COMMON MERRILL LYNCH

555 CALIFORNIA ST SAN FRANCISCO CA 94104

4049 80984.00 73105580 06/07/2023 NASDAQ COMMON 12/15/2022 RESTRICTED STOCK UNIT ARCUS BIOSCIENCES N 2030 12/15/2022 EQUITY COMPENSATION COMMON 12/15/2021 RESTRICTED STOCK UNIT ARCUS BIOSCIENCES N 2019 12/15/2021 EQUITY COMPENSATION Y 06/07/2023 03/07/2023 ROBERT GOELTZ